Kamada (KMDA) Gross Profit (QoQ) (2013 - 2026)
Kamada (KMDA) Gross Profit (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Kamada | 400.07 Mn | 326.92 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.67% |
| Dec 31, 2025 | -14.14% |
| Sep 30, 2025 | -99.90% |
| Jun 30, 2025 | 91,128.49% |
| Mar 31, 2025 | 21.83% |
| Dec 31, 2024 | -1.18% |
| Sep 30, 2024 | -99.91% |
| Jun 30, 2024 | 113,033.54% |
| Mar 31, 2024 | 16.23% |
| Dec 31, 2023 | -2.64% |
| Sep 30, 2023 | 2.54% |
| Jun 30, 2023 | -99.88% |
| Mar 31, 2023 | 77,324.63% |
| Dec 31, 2022 | -99.88% |
| Sep 30, 2022 | 177,662.43% |
| Jun 30, 2022 | -35.94% |
| Mar 31, 2022 | 71.37% |
| Dec 31, 2021 | 15.10% |
| Sep 30, 2021 | -36.84% |
| Jun 30, 2021 | 1.58% |